FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to chemical and pharmaceutical industries and is a pharmaceutical antitumor composition based on salt of N,N-dimethylaminoethylamide 1’-des-(2,3-dihydroxy-n-butyroyl)-1’-carboxyiolimicin A, selected from the group of methanesulfonate, hydrochloride, citrate and fumarate of N,N-dimethylaminoethylamide 1’-des-(2,3-dihydroxy-n-butyroyl)-1’-carboxyiolimicin A. Invention allows obtaining a pharmaceutical composition that is more stable when stored with an appropriate or greater antitumor activity than a free base N,N-dimethylaminoethylamide 1’-des-(2,3-dihydroxy-n-butyroyl)-1’-carboxyiolimicin A.
EFFECT: pharmaceutical antitumor composition is proposed.
7 cl, 7 dwg, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SEMI-SYNTHETIC ANALOGUES OF AUREOLIC ACID OLIVOMYCIN A ANTIBIOTIC, HAVING ANTI-TUMOUR ACTIVITY, AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2453552C2 |
| ANTITUMOUR ANTHRAFURANDIONE AND BASED PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2554939C1 |
| ANTIFUNGAL SEMI-SYNTHETIC POLYENE ANTIBIOTIC, WATER-SOLUBLE SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2018 |
|
RU2688658C1 |
| DERIVATIVES OF OLIVOMYCIN 1, ANTIBIOTIC OF AUREOLIC ACID GROUP WITH ANTICANCER ACTIVITY, AND METHOD OF PRODUCTION THEREOF | 2007 |
|
RU2350621C1 |
| STABLE LYOPHILIZATES CONTAINING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID | 2018 |
|
RU2796570C2 |
| COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
| ANTICANCER PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING BREAST CANCER | 2015 |
|
RU2581022C1 |
| PHARMACEUTICAL COMPOSITION ELICITING IMPROVED ANTITUMOR EFFECT AND/OR REDUCED ADVERSE EFFECTS AND COMPRISING ANTITUMOR AGENT AND DERIVATIVE OF HYDROXAMIC ACID | 1998 |
|
RU2254129C2 |
| CYTOTOXIC LINEAR HETEROCYCLIC DERIVATIVES OF ANTHRACENEDIONE HAVING IN SIDE CHAIN CYCLIC DIAMINES, ACTIVE TOWARDS TUMOUR CELLS WITH MULTIDRUG RESISTANCE | 2009 |
|
RU2412166C1 |
| ANTI-TUMOR NAPHTHOINDOLE-3-CARBOXAMIDE DERIVATIVE | 2019 |
|
RU2712191C1 |
